Lyme Disease: Understanding Why It's So Controversial and Hard to Treat

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Updated April 2026 | Medical Advisor: Nikhil Joshi, MD, FRCPC

Lyme Disease: Understanding Why It's So Controversial and Hard to Treat

If you want to start an argument in medicine, bring up Lyme disease. Few infections generate as much disagreement between doctors, between patients and doctors, and between different medical organizations. On one side, patients suffering with real, debilitating symptoms that will not go away. On the other side, a medical establishment that struggles to explain what is happening once the textbook timeline runs out.

The controversy is not because people are being stubborn. It is because the bacterium that causes Lyme disease — called Borrelia — is one of the most sophisticated escape artists in all of microbiology. Understanding its tricks is the key to understanding why this disease is so difficult.

The biology of Borrelia burgdorferi explains why some patients don't improve with standard treatment. The science is real. The debate is about what to do about it.

Meet the Enemy: Borrelia, the Corkscrew

Most bacteria are round or rod-shaped. Borrelia is a spirochete — a long, thin, corkscrew-shaped bacterium that moves by rotating its entire body like a drill bit. This shape is not cosmetic. It is a tool. Borrelia's corkscrew design lets it bore through tissues that would stop other bacteria cold. It can penetrate the gel-like matrix between cells, drill into cartilage, cross the walls of blood vessels, and even breach the blood-brain barrier.

Think of the difference between pushing a stick through thick mud versus screwing a corkscrew through a cork. The corkscrew gets through with far less force. Borrelia uses this same mechanical advantage to reach places in the body that are normally well-protected from infection — joints, the heart, the nervous system, the eyes.

Borrelia is also remarkably slow-growing compared to most bacteria. While E. coli divides every 20 minutes, Borrelia divides once every 12 to 18 hours. This slow growth rate matters for treatment because many antibiotics work best against rapidly dividing bacteria. A slowly dividing target is harder to hit.

The Tick's Dirty Needle: How Transmission Works

Borrelia lives in the gut of blacklegged ticks (also called deer ticks). When a tick attaches to your skin and begins feeding, the bacteria do not immediately jump into your bloodstream. They sit in the tick's gut and wait.

As the tick feeds — which can take days — the bacteria sense the change in temperature and chemistry that tells them they are now connected to a warm-blooded host. This triggers Borrelia to change its surface proteins and migrate from the tick's gut to its salivary glands. From there, the bacteria flow into the bite wound along with the tick's saliva.

This process takes time. The commonly cited window is 24 to 36 hours, though some research suggests transmission can begin earlier in certain circumstances. This is why finding and removing ticks quickly matters so much — the bacteria literally need time to prepare for the journey.

The tick's saliva itself is a remarkable cocktail of immune-suppressing chemicals. It contains compounds that numb the skin (so you do not feel the bite), prevent blood clotting (so the blood keeps flowing), and suppress the local immune response (so the body does not react and reject the tick). Borrelia essentially hitches a ride on this immune-suppressing wave, entering the body through a door that the tick's saliva has already opened.

The Master of Disguise: How Borrelia Evades the Immune System

Here is where Borrelia really earns its reputation. Most bacteria have a fixed set of surface proteins — molecular identity badges that the immune system learns to recognize. Once your immune system identifies these badges, it can target and destroy the bacteria. This is the basic principle behind how your body fights most infections.

Borrelia does not play by these rules. It has a large collection of genes that encode different surface proteins, and it can switch between them. Imagine a fugitive who can change their face, their fingerprints, and their voice at will. Every time the immune system learns to recognize one disguise, Borrelia switches to another.

The main surface protein involved in this trick is called VlsE (variable major protein-like sequence, expressed). The gene for VlsE sits next to a library of silent gene cassettes — alternative versions of the protein that are stored but not used. Borrelia can swap segments of the active gene with segments from the silent cassettes, creating new combinations. The number of possible variations is astronomically large — far more than the immune system can keep up with.

This is not a passive defense. It is an active, ongoing deception. The bacteria are constantly generating new surface identities, staying one step ahead of the immune system's targeting. This is one of the key reasons why the immune system often fails to clear Borrelia completely, even in people with healthy immune function.

The Fortress: Biofilm Formation

As if shape-shifting were not enough, Borrelia can also build biofilms — sticky, protective communities of bacteria encased in a self-produced matrix. If you have ever seen the slimy film on a rock in a stream, you have seen a biofilm. Bacteria inside biofilms are dramatically more resistant to antibiotics — sometimes 1,000 times more resistant than the same bacteria floating freely in the bloodstream.

The biofilm matrix acts as a physical barrier that antibiotics cannot penetrate easily. It also slows bacterial metabolism, which further reduces antibiotic effectiveness since many antibiotics target metabolically active cells. And it shields the bacteria from immune cells, which cannot engulf or kill bacteria that are embedded in this protective structure.

Laboratory research has shown that Borrelia can form biofilms both in test tubes and in living tissue. The clinical significance of these biofilms — meaning how much they contribute to persistent symptoms in actual patients — remains debated. But the basic science is clear: Borrelia has the ability to build fortresses that are very hard to breach.

The Testing Problem: Why Lyme Is So Hard to Diagnose

If you want to know whether someone has a strep throat, you swab their throat and grow the bacteria. If you want to know whether someone has Lyme disease, you... cannot do this. Borrelia is extremely difficult to grow in the laboratory. It requires special media, takes weeks to grow, and often does not grow at all even from genuinely infected patients.

Instead, standard Lyme testing relies on detecting antibodies — the immune system's response to the bacteria, rather than the bacteria themselves. The standard approach is a two-tier test: first a screening test (ELISA), and if that is positive or borderline, a confirmatory test (Western blot).

This approach has real limitations. Antibodies take weeks to develop, so testing in the first days after infection often gives false negatives. Some patients, particularly those treated early with antibiotics, may never develop a robust antibody response. And the tests were designed to be highly specific (few false positives) at the cost of sensitivity (more false negatives). This means that a positive test is very reliable, but a negative test does not rule out infection.

There is a deep irony here. The patients who are most likely to have diagnostic uncertainty — those with vague, persistent symptoms months after possible exposure — are also the ones for whom antibody testing is least reliable. They may have been treated early (suppressing the antibody response), or Borrelia's immune evasion may have prevented a strong antibody response, or enough time may have passed that antibody levels have waned.

The Nervous System Invasion: Neuroborreliosis

Borrelia's corkscrew shape and active motility allow it to do something most bacteria cannot — cross the blood-brain barrier and enter the central nervous system. This is called neuroborreliosis, and it can happen weeks to months after the initial tick bite.

Once inside the nervous system, Borrelia can cause inflammation of the membranes surrounding the brain and spinal cord (meningitis), damage to specific cranial nerves (most commonly the facial nerve, causing a sudden drooping of one side of the face), and inflammation of nerve roots (radiculopathy) causing pain, numbness, or weakness.

In some cases, neuroborreliosis affects the brain itself, causing difficulties with memory, concentration, and processing speed. Patients describe a cognitive fog that makes it hard to think clearly, find words, or follow conversations. Brain imaging studies have shown areas of inflammation and reduced blood flow in patients with neurological Lyme disease.

The Controversy: What Happens After Treatment

This is where Lyme disease splits the medical world. The standard treatment for Lyme disease is a course of antibiotics, typically two to four weeks. For many patients, this works. Symptoms resolve, and they return to normal.

But a significant minority of patients — estimates range from 10 to 20 percent — continue to experience symptoms after completing standard treatment. Fatigue, pain, cognitive difficulties, and other problems persist for months or years. This is real suffering that no one disputes. The argument is about what causes it.

The mainstream medical position, represented by the Infectious Diseases Society of America, holds that the antibiotics successfully eliminate the bacteria and that persistent symptoms result from residual tissue damage and ongoing immune activation — a kind of aftershock following the infection. They call this post-treatment Lyme disease syndrome.

The opposing view, held by many patients and some physicians, argues that Borrelia can survive standard antibiotic courses — hiding in biofilms, inside cells, or in forms that are resistant to the antibiotics used. They believe that persistent symptoms reflect ongoing, active infection that requires additional or different treatment. They use the term chronic Lyme disease.

The honest answer is that science has not fully resolved this question. There is laboratory evidence showing that Borrelia can survive antibiotic exposure under certain conditions. There are animal studies where bacterial DNA has been detected after antibiotic treatment. But there is not yet definitive proof that living, active bacteria persist in treated human patients and cause ongoing symptoms.

What is clear is that the symptoms are real, the suffering is genuine, and the current state of testing and treatment is insufficient for a subset of patients. Whether the cause is persistent infection, immune dysregulation triggered by the infection, tissue damage, or some combination — the experience of illness is the same, and it deserves to be taken seriously.

What This Means for Caregivers

Caring for someone with persistent Lyme disease can be extraordinarily frustrating. You are navigating a medical landscape where even the experts disagree. Tests may be inconclusive. Doctors may dismiss symptoms. The person you are caring for may feel unheard and disbelieved.

Understanding the biology helps. When you know that Borrelia can change its surface proteins, form biofilms, and invade the nervous system, the idea that some patients have persistent symptoms becomes much less mysterious. You do not need to pick a side in the medical debate to understand that this is a genuinely complicated infection caused by a genuinely sophisticated pathogen.

Questions to Bring to Your Doctor

Understanding the biology gives you better questions. Here are ones worth asking:

Our 14 AI research agents can analyze your specific situation across the full landscape of published research — finding connections your medical team may not have time to search for. It takes five minutes.

Frequently Asked Questions

Why does Lyme disease need to be caught early?

In the first days and weeks after a tick bite, Borrelia bacteria are still in the bloodstream and relatively exposed to the immune system and antibiotics. Once the bacteria spread to tissues like joints, the heart, and the nervous system, they become much harder to reach. They can hide inside cells, form protective biofilms, and change their surface proteins to evade immune detection. Early treatment catches them before they deploy these escape strategies.

Why do standard Lyme disease tests sometimes come back negative even when someone is infected?

Standard Lyme tests do not detect the bacteria directly. They detect antibodies — your immune system's response to the bacteria. This creates two problems. First, it takes weeks for the body to produce enough antibodies to be detectable, so early infections are often missed. Second, if the immune system is suppressed or if Borrelia is evading immune detection effectively, antibody levels may stay too low to trigger a positive result even in a genuine infection.

What is the difference between Lyme disease and chronic Lyme disease?

Acute Lyme disease is the initial infection caused by Borrelia bacteria transmitted through a tick bite. It is well-accepted by all medical authorities. The controversy surrounds patients who continue to have symptoms after standard antibiotic treatment. The mainstream medical term for this is post-treatment Lyme disease syndrome. Some doctors and patient advocates use the term chronic Lyme disease, which implies ongoing active infection. The debate centers on whether persistent symptoms are caused by surviving bacteria or by lasting immune and tissue damage from the initial infection.

Can Lyme disease affect the brain?

Yes. Borrelia bacteria can cross the blood-brain barrier and invade the central nervous system, a condition called neuroborreliosis. This can cause inflammation of the brain and spinal cord membranes (meningitis), damage to cranial nerves (especially facial nerve palsy), cognitive difficulties, and in some cases, psychiatric symptoms. The bacteria's corkscrew shape and active motility help them penetrate tissues that many other bacteria cannot reach.

Why is Lyme disease more common in some regions than others?

Lyme disease requires a specific chain: Borrelia bacteria living inside blacklegged ticks (Ixodes species), which feed on animal hosts like white-footed mice and deer. The disease is most common in regions where all elements of this chain thrive — the northeastern and upper midwestern United States, parts of Europe, and parts of Asia. Climate, wildlife populations, land use patterns, and human outdoor activity all influence local Lyme disease risk.